Ferhat Meziani
Overview
Explore the profile of Ferhat Meziani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
151
Citations
8987
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Curtiaud A, Iba T, Angles-Cano E, Meziani F, Helms J
Ann Intensive Care
. 2025 Jan;
15(1):12.
PMID: 39821561
Diagnosing coagulopathy in septic patients remains challenging in intensive care. Disseminated intravascular coagulation (DIC) indeed presents with complex pathophysiology, complicating timely diagnosis. Epidemiological data indicate a significant prevalence of DIC...
2.
Helms J, Meziani F, Angles-Cano E
Anesthesiology
. 2025 Jan;
142(2):421-423.
PMID: 39807927
No abstract available.
3.
Landoni G, Chowdary P, Meziani F, Creteur J, De Schryver N, Motsch J, et al.
Ann Intensive Care
. 2024 Nov;
14(1):170.
PMID: 39522090
Background: Pulmonary intravascular thrombus formation has been widely observed in patients with respiratory failure, for example, in patients with SARS-CoV-2 infection (COVID-19). The aim of this study was to evaluate...
4.
Helms J, Meziani F, Mauvieux L, Iba T
Juntendo Iji Zasshi
. 2024 Oct;
70(2):114-117.
PMID: 39430204
Neutrophils serve as the frontline defenders in the host's response to infections. However, the available methods for assessing the activated status of neutrophils are still limited. The immature cells that...
5.
Tran K, Asfar P, Cheng M, Demiselle J, Singer J, Lee T, et al.
Clin Infect Dis
. 2024 Sep;
79(3):615-625.
PMID: 39325643
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) down-regulates angiotensin-converting enzyme 2, potentially increasing angiotensin II. We hypothesized that losartan compared to usual care decreases mortality and is safe in...
6.
Meziani F, Iba T, Levy J, Helms J
Intensive Care Med
. 2024 Jun;
50(8):1404-1405.
PMID: 38856751
No abstract available.
7.
Helms J, Curtiaud A, Severac F, Tschirhart M, Merdji H, Bourdin M, et al.
Anesthesiology
. 2024 Mar;
141(1):75-86.
PMID: 38502917
Background: Extracorporeal membrane oxygenation (ECMO) is associated with a high risk of bleeding complications. The specific impact of ECMO on fibrinolysis remains unexplored. The objective of the current pilot observational...
8.
Chomel L, Vogt M, Demiselle J, Le Borgne P, Tschirhart M, Morandeau V, et al.
J Innate Immun
. 2024 Mar;
16(1):216-225.
PMID: 38461810
Introduction: Toll-like receptors play crucial roles in the sepsis-induced systemic inflammatory response. Septic shock mortality correlates with overexpression of neutrophilic TLR2 and TLR9, while the role of TLR4 overexpression remains...
9.
Helms J, Merdji H, Loewert S, Severac F, Monnier A, Kaurin J, et al.
Ann Intensive Care
. 2023 Dec;
13(1):119.
PMID: 38038826
Background: Disseminated intravascular coagulation (DIC) worsens the prognosis of septic shock and contributes to multiple organ failure. To date, no data linking DIC and acute kidney injury (AKI) occurrence, severity,...
10.
Helms J, Meziani F, Angles-Cano E
Intensive Care Med
. 2023 Nov;
49(12):1569-1570.
PMID: 37982825
No abstract available.